SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-096084
Filing Date
2007-04-30
Accepted
2007-04-30 16:49:25
Documents
3
Period of Report
2007-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15642
2 AGREEMENT dex10243.htm EX-10.243 8919
3 PRESS RELEASE dex991.htm EX-99.1 8679
  Complete submission text file 0001193125-07-096084.txt   34879
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27570 | Film No.: 07801229
SIC: 8731 Services-Commercial Physical & Biological Research